Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biopharma industry
Biotech
BMS unites R&D as chief of research departs—Chutes & Ladders
BMS unites R&D as research chief departs. Summit cuts commercial team. OncoNano makes its CEO appointment permanent.
Donavyn Coffey
,
Marissa Russo
Nov 13, 2026 8:30am
Fierce Biotech Layoff Tracker 2026: Milestone, Cellectis & more
Nov 13, 2026 7:00am
Novo saying goodbye to longtime finance chief—Chutes & Ladders
Nov 6, 2026 10:12am
GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders
Oct 23, 2026 8:30am
Bausch + Lomb CEO heads for exit once more—Chutes & Ladders
Oct 16, 2026 8:30am
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am